Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1 as well as synthesis, activity and application thereof
The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the comp...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
14.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the compounds on a tissue factor/blood coagulation factor VII, and discloses the venous thrombosis resisting effect of the compounds.
本发明公开了4种华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA化合物,公开了它们的制备方法,公开了它们无出血副作用的优点,公开了它们对凝血因子II的拮抗作用,公开了它们对组织因子/凝血因子VII的拮抗作用,公开了它们的抗静脉血栓作用。 |
---|---|
AbstractList | The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds without bleeding side effects, an antagonistic effect of the compounds on a blood coagulation factor II, and an antagonistic effect of the compounds on a tissue factor/blood coagulation factor VII, and discloses the venous thrombosis resisting effect of the compounds.
本发明公开了4种华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA化合物,公开了它们的制备方法,公开了它们无出血副作用的优点,公开了它们对凝血因子II的拮抗作用,公开了它们对组织因子/凝血因子VII的拮抗作用,公开了它们的抗静脉血栓作用。 |
Author | PENG SHIQI ZHAO MING HOU MENGYU ZHANG XIAOYI |
Author_xml | – fullname: HOU MENGYU – fullname: ZHANG XIAOYI – fullname: ZHAO MING – fullname: PENG SHIQI |
BookMark | eNqNzbsKwjAUgOEMOnh7h7h7htiCdCzFy6QOgpvl0J5oIJyEJCh5eyv6AE7f8sM_FSN2TBNxu2LQGAxDCSfAjlK2sLcZzsFBHe5fayUxyhdZ-zFmTg-KJq4kdsk8TcoSuZfovTUdJuNYDkEgp-dirNFGWvycieVue2kOQN61FP0wZEptc1SqqNbVplR18U_zBmsCPKI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 华法林-4-O-乙酰-Gly-Pro-Arg-Pro-AA1及其合成、活性和应用 |
ExternalDocumentID | CN113929741A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN113929741A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:25:01 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN113929741A3 |
Notes | Application Number: CN202010602719 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220114&DB=EPODOC&CC=CN&NR=113929741A |
ParticipantIDs | epo_espacenet_CN113929741A |
PublicationCentury | 2000 |
PublicationDate | 20220114 |
PublicationDateYYYYMMDD | 2022-01-14 |
PublicationDate_xml | – month: 01 year: 2022 text: 20220114 day: 14 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | CAPITAL UNIVERSITY OF MEDICAL SCIENCES |
RelatedCompanies_xml | – name: CAPITAL UNIVERSITY OF MEDICAL SCIENCES |
Score | 3.5045538 |
Snippet | The invention discloses four kinds of warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA compounds, a preparation method of the compounds, an advantage of the compounds... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1 as well as synthesis, activity and application thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220114&DB=EPODOC&locale=&CC=CN&NR=113929741A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7mFPVNp6LzBxGkTwbtmq3rQ5Et3RzCuiFT96QkbaaT0Y62IvOv91I3txd9SkjgSA7uvu8uuQTgQjjCUgKZm2BKUOZUbCoCKSn6SluaVliTlq5G7vq1zgO7G1aHBXhf1MLk74R-5o8jokUFaO9Z7q-nyySWl9-tTK_kGIfim_bA9Yx5dFzRcMYMr-m2-j2vxw3OXe4b_r1rmpoIIHw21mAdabStraH12NRVKdNVSGnvwEYfpUXZLhS-3kqwxRc_r5Vgszs_8Mbu3PbSPXh-EskII9uIMtrDrapsNqG3kxntJzFtJK8_bcMkIiU6I6fbdBYhwUvH6SXRBQz6nwgiopCsHFsTzQBVPNqH83ZrwDsUF_ryq5UX7i_3ZB1AMYojdQjEDhyFwOcE8rqOoZcU9SCUimG8GVarStaOoPy3nPJ_k8ewrTWs8w8mO4FilnyoU0TkTJ7lqvwGHbSQ-A |
link.rule.ids | 230,309,783,888,25576,76882 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VROzJxsdKx97WAxsICoMYlB5krRbUQzZyDZj8K_3OkF50ac2bdK0l1x_v7v27gDOuMkNyZG5cSY5ZWaxQrknBMW7siJ0wy8LQ0Ujd9xy64HdDkqDDLwtYmHSPKEfaXJE1CgP9T1J7-vprxPLSf9WxhdijEPhVbNvOdrcOi4qOGOaU7cava7TtTXbtmxXc-8tXVdEAOGztgKrSLGrqtpB47GuolKmy5DS3IS1Hq4WJFuQ-XzNQ85eVF7Lw3pn_uCN3bnuxdvw_MSjEVq2AWW0i0eVyWxCrycz2otCWotevtuaTnhMlEdOtfEsQIIXj-NzogIYVJ0IwgOfLD1bE8UAZTjagdNmo2-3KG50-COVoe3-nsnYhWwQBnIPSMUzJQKf6YnLKppeglc9X0iG9qZfKklR3ofC3-sU_ps8gVyr32kP2zfu3QFsKGkrX4TODiGbRO_yCNE5EcepWL8AEwWT6A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Warfarin-4-O-acetyl-Gly-Pro-Arg-Pro-AA1+as+well+as+synthesis%2C+activity+and+application+thereof&rft.inventor=HOU+MENGYU&rft.inventor=ZHANG+XIAOYI&rft.inventor=ZHAO+MING&rft.inventor=PENG+SHIQI&rft.date=2022-01-14&rft.externalDBID=A&rft.externalDocID=CN113929741A |